Harousseau Jl
About
In The Last Decade
Harousseau Jl
41 papers receiving 730 citations
Peers
Comparison fields: 5 of 54
- Hematology 607
- Molecular Biology 350
- Oncology 301
- Immunology 112
- Genetics 84
Countries citing papers authored by Harousseau Jl
This map shows the geographic impact of Harousseau Jl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harousseau Jl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harousseau Jl more than expected).
Fields of papers citing papers by Harousseau Jl
This network shows the impact of papers produced by Harousseau Jl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harousseau Jl. The network helps show where Harousseau Jl may publish in the future.
Co-authorship network of co-authors of Harousseau Jl
This figure shows the co-authorship network connecting the top 25 collaborators of Harousseau Jl. A scholar is included among the top collaborators of Harousseau Jl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harousseau Jl. Harousseau Jl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 91 | |
| 2 | 13 | |
| 3 | 65 | |
| 4 | 2 | |
| 5 | 11 | |
| 6 | 183 | |
| 7 | 13 | |
| 8 | 36 | |
| 9 | Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma. | 42 |
| 10 | 18 | |
| 11 | [Cerebral granulocytic sarcoma disclosing acute non-lymphoblastic leukemia]. | 1 |
| 12 | [First-line treatment of severe myelomas of the young subject by high-dose melphalan]. | 2 |
| 13 | [Allogenic bone marrow grafts in acute myeloid leukemias. A retrospective study in 111 grafted patients in first complete remission]. | 5 |
| 14 | [Acute myeloblastic leukaemia in the course of non-Hodgkin's lymphoma (author's transl)]. | 1 |
| 15 | Application of the study of prognostic factors to the treatment of childhood (less than 20 years old) acute lymphoblastic leukemia. | 3 |
| 16 | [Acute lymphoblastic leukemia with hyperleucocytosis: an urgent problem during initial treatment (author's transl)]. | 1 |
| 17 | [Cutaneous lesions of malignant histiocytosis. About five cases (author's transl)]. | 1 |
| 18 | [Cases of acute leukaemia following immunosuppressive therapy for disseminated sclerosis and for Behçet's syndrome (author's transl)]. | 4 |
| 19 | [Acute granulous leukemia in multiple myeloma. Apropos of 5 cases]. | 1 |
| 20 | [Inagural lymphoblatic transformation in chronic myeloid leukemia. Clinical and cytogenetic study of one case]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.